Cardiometabolic Health Congress

NOVEMBER 22, 2024

From breakthrough medications to innovative technologies, there is a lot for cardiometabolic clinicians professionals to celebrate. Tirzepatide’s Dual Benefits in Obesity : Recent studies on tirzepatide , a GLP-1 receptor agonist, revealed significant weight loss and improved outcomes in sleep apnea patients.

Blood Pressure 52

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection. In the U.S.,

CME 96

CME Obesity Heart Failure Biomarkers 96

Cardiometabolic Health Congress

OCTOBER 25, 2024

The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations. Learn more now!

CME 64

CME Innovation Education Atherosclerosis 64

Dr. Malcolm Kendrick

OCTOBER 30, 2024

In the Sunday Times of April 23 rd , 2017, this article appeared, entitled ‘ Kellogg’s smothers health crisis in sugar – The cereals giant is funding studies that undermine official warnings on obesity.’ The study, published in the Journal Obesity Facts relied on evidence from 14 studies. Just to choose a few paragraphs. ‘

Cholesterol 145

Cholesterol Article Research Diet 145